A REVIEW ON: “TARGETED CANCER THERAPY & THEIR DRUGS”

Registration ID: IJNRD_183654

Published ID: IJNRD2210161

DOI: Click Here to Get

Shubhangi Balasaheb Mahandule , Mayur Kisan Kolhatkar , Shruti Sonawane , Saurabh Rajendra Jagtap , Sonali Anil mane

cancer, metastatic, chemotherapy, Targeted therapy, radiation.

People with advanced and metastatic non-small cell lung cancer (NSCLC) that responds to targeted therapies or check point inhibitors now routinely survive for three or four years after diagnosis, and a lucky few live substantially longer. Chemotherapy and targeted therapy are both treatments that attacks cancer cells. Targeted therapy is less toxic to healthy cells than chemotherapy. Both options are often done in conjunction with other treatments, such as radiation. Before you have some types of targeted drugs you might need to have tests using some of your cancer cells or a blood sample. This is to find out whether the treatment is likely to work. These tests look for changes in certain proteins or genes. Your cancer specialist can tell you if this applies to your treatment.

Published Paper   E-Certificate

Shubhangi Balasaheb Mahandule, Mayur Kisan Kolhatkar, Shruti Sonawane , Saurabh Rajendra Jagtap, & Sonali Anil mane (October-2022). A REVIEW ON: “TARGETED CANCER THERAPY & THEIR DRUGS”. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 7(10), 285-296. https://ijnrd.org/papers/IJNRD2210161.pdf

Volume 7 Issue 10, October-2022

Pages : 285-296

Paper Reg. ID: IJNRD_183654

Published Paper Id: IJNRD2210161

Downloads: 000121987

Research Area: Pharmacy

Country: Ahmednagar, Maharashtra, India

Published Paper PDF: https://ijnrd.org/papers/IJNRD2210161.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2210161

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG

This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition

Call For Paper - Volume 10 | Issue 10 | October 2025

IJNRD is a Scholarly Open Access, Peer-reviewed, and Refereed Journal with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost Journal that follows UGC CARE 2025 Peer-Reviewed Journal Policy norms, Scopus journal standards, and Transparent Peer Review practices to ensure quality and credibility. IJNRD provides indexing in all major databases & metadata repositories, a citation generator, and Digital Object Identifier (DOI) for every published article with full open-access visibility.

The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse fields. Its goal is to promote global scientific information exchange among researchers, developers, engineers, academicians, and practitioners. IJNRD serves as a platform where educators and professionals can share research evidence, models of best practice, and innovative ideas, contributing to academic growth and industry relevance.

Indexing Coverage includes Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many more recognized academic repositories.

How to submit the paper?

By Our website

Click Here to Submit Paper Online

By Mail

Send your paper to editor@ijnrd.org

Important Dates for Current issue

Paper Submission Open For: October 2025

Current Issue: Volume 10 | Issue 10 | October 2025

Impact Factor: 8.76

Last Date for Paper Submission: Till 31-Oct-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.

Subject Category: Research Area

Call for Paper: More Details